Chemokines Acting via CXCR2 and CXCR4 Control the Release of Neutrophils from the Bone Marrow and Their Return following Senescence  by Martin, Coralie et al.
Immunity, Vol. 19, 583–593, October, 2003, Copyright 2003 by Cell Press
Chemokines Acting via CXCR2 and CXCR4
Control the Release of Neutrophils from the Bone
Marrow and Their Return following Senescence
al.,1998). In all of these studies, where chemotaxis of
neutrophils toward SDF-1 was assessed, no response
was observed. It has been reported that the expression
of CXCR4 on neutrophils is dramatically upregulated
as they age in culture (Nagase et al., 2002) and that
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that the gradient of chemokine created across the sinusIn this study we provide evidence that the SDF-1/
endothelium stimulates chemotaxis of neutrophils pres-CXCR4 chemokine axis is involved in both the reten-
ent in the hematopoietic compartment and induces theirtion of neutrophils within the bone marrow and the
migration across the bone marrow sinusoidal endothe-homing of senescent neutrophils back to the bone
lium, such that they can be liberated into the systemicmarrow. We show that the functional responses of
circulation. In this study we tested the hypothesis that,freshly isolated human and murine neutrophils to
in addition to factors such as chemokines, that areCXCR2 chemokines are significantly attenuated by
known to directly stimulate release (Jagels and Hugli,SDF-1, acting via CXCR4. As a consequence, the
1992; Terashima et al., 1998), there may also be mecha-mobilization of neutrophils from the bone marrow in
nisms promoting the retention of neutrophils within thevivo by the CXCR2-chemokine, KC, was dramatically
bone marrow, and it is the balance between these twoenhanced by blocking the effects of endogenous
opposing signals that determines the rate of neutrophilSDF-1 using a specific CXCR4 antagonist. As neutro-
release from the bone marrow during an inflammatoryphils age, they upregulate expression of CXCR4 and
episode. In particular we have examined the possibilityacquire the ability to migrate toward SDF-1. We show
that the chemokine SDF-1, which is expressed consti-here that these senescent CXCR4high neutrophils pref-
tutively in the bone marrow, acts as a retention factorerentially home to the bone marrow in vivo in a CXCR4-
for neutrophils in this tissue.
dependent manner, suggesting a previously undefined
It is estimated that in humans 1011 neutrophils are
mechanism for the clearance of senescent neutrophils released from the bone marrow per day. As these neu-
from the circulation. trophils have a short half-life (t1/2 6 hr) in the circulation,
homeostatic mechanisms are essential to ensure their
Introduction efficient clearance from the blood. It is thought that
senescent neutrophils are cleared from the blood by
SDF-1/CXCL12 acts solely on one receptor CXCR4 that the liver, spleen, and bone marrow, but the molecular
is expressed by CD34 progenitors, megakaryocytes, mechanisms regulating this clearance have not been
platelets, B cells, T cells, and mononuclear phagocytes established (Thakur et al., 1977, Saverymuttu et al., 1985;
(Bleul et al., 1996, 1997; Hori et al., 1998; Forster et al., Lovas et al., 1996; Suratt et al., 2001). At inflammatory
1998; Mohle et al., 1998; Kowalska et al., 1999). It has sites as neutrophils age they become apoptotic, thereby
previously been reported that neutrophils express changing their phenotype such that they are recognized
CXCR4 mRNA (Patel et al., 2001; Loetscher et al., 1998; and phagocytosed by tissue macrophages (Haslett,
Gonzalo et al., 2000). However, while some studies re- 1999). It is not known whether circulating neutrophils
port surface expression of CXCR4 on neutrophils (For- must also exhibit an apoptotic phenotype to promote
ster et al., 1998; Bruhl et al., 2001), others report its their clearance, or whether there are other distinct mech-
absence (Bleul et al., 1996; Nagase et al., 2002; Hori et anisms for the clearance of senescent neutrophils from
the circulation. We hypothesized that as neutrophils age,
upregulation of CXCR4 promotes the trafficking of se-*Correspondence: s.rankin@imperial.ac.uk
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Figure 1. Neutrophil CXCR4 and CXCR2 Cell Surface and Intracellular Expression and Chemotactic Responses to SDF-1 and Gro-
(A) Surface expression of CXCR4 and CXCR2 on freshly isolated human blood neutrophils measured by flow cytometry; mean  SEM (n 
6 separate experiments performed in triplicate).
(B) Migration of freshly isolated human blood neutrophils to SDF-1 (50 nM) and Gro- (10 nM) measured using a Transwell chemotaxis assay;
mean  SEM (n  6 separate experiments performed in triplicate).
(C) Cell surface (ext.) and intracellular staining (int.) of CXCR4 on freshly isolated human blood neutrophils measured by flow cytometry; cont.,
isotype matched control mAb.
nescent/preapoptotic CXCR4high neutrophils back to the change assay was performed (GAFS assay, Sabroe et
al., 1999). A robust concentration-dependent shapebone marrow. We propose, therefore, that the homing
of senescent neutrophils back to the bone marrow, in change of neutrophils was observed in response to both
IL-8 and Gro-, as has previously been reported (Figuresa CXCR4-dependent manner, may represent a novel
pathway for the clearance of senescent neutrophils from 2A and 2B; Sabroe et al., 1999). In contrast to these
chemokines, SDF-1 stimulated only a partial shapethe circulation.
In this study we have investigated the potential role change. However, as shown in Figures 2A, 2C, 2D, and
2E the response of neutrophils to Gro-, ENA-78, andof endogenous SDF-1 to act as a retention factor for
mature neutrophils in the bone marrow. Furthermore, NAP-2 was significantly reduced by their coincubation
with SDF-1. The inhibitory effect of SDF-1 on re-we have investigated the hypothesis that upregulation
of CXCR4 on neutrophils as they age promotes the traf- sponses to Gro-, ENA-78, and NAP-2 was completely
abrogated by both the CXCR4 antagonist, AMD-3100ficking of senescent neutrophils back to the bone mar-
row. These data reveal a dynamic relationship between (Hatse et al. 2002), and a specific CXCR4 blocking mAb
(Figures 2A, 2C, 2D, and 2E). In contrast, neutrophilthe chemokine receptors CXCR4 and CXCR2 and their
ligands in determining both the release and clearance responses to IL-8 were unaffected by SDF-1 coincuba-
tion (Figures 2B and 2F). Neutrophil shape change inof neutrophils by the bone marrow.
response to Gro-, ENA-78, and NAP-2 was markedly
reduced by pretreatment with the CXCR2 antagonistResults
SB225002, while the response to IL-8 was unaffected by
this antagonist (Figures 2A–2F). Taken together, theseFreshly Isolated Human Blood Neutrophils Express
Low Levels of CXCR4 and Do Not Migrate results suggest that neutrophil responses to CXCR2 ag-
onists, but not CXCR1 agonists, can be significantlytoward SDF-1
Flow cytometry staining was performed to directly as- attenuated by SDF-1 acting via CXCR4.
To determine whether SDF-1 downregulates surfacesess cell surface and intracellular levels of CXCR4 and
CXCR2 on human blood neutrophils. Freshly isolated expression of CXCR2, neutrophils were incubated with
SDF-1 for 0–60 min at 37C and levels of CXCR2 cellneutrophils were shown to express very low levels of
CXCR4 on their cell surface while intracellular levels of surface expression subsequently assessed by flow cy-
tometry. As shown in Figure 2G, expression of CXCR2CXCR4 were high (Figures 1A and 1C). In contrast,
freshly isolated neutrophils expressed high cell surface on the surface of neutrophils was unaffected by their
incubation with SDF-1.levels of CXCR2 (Figure 1A). Examination of neutrophils
stained with mAbs to CXCR4 by confocal microscopy,
confirmed the flow cytometry data (data not shown). To SDF-1 Suppresses Chemotaxis of Neutrophils
in Response to Chemokines Acting via CXCR2determine whether neutrophils responded functionally
via these receptors, chemotaxis assays were carried We next examined whether SDF-1 could also affect
neutrophil chemotaxis toward chemokines acting viaout. As shown in Figure 1B, freshly isolated neutrophils
migrated in response to Gro- but not to SDF-1 at 50 CXCR2. As a prelude to in vivo experiments, murine
bone marrow neutrophils (which have CXCR2, but lacknM (Figure 1B) or over a concentration range 1–100 nM
(data not shown). CXCR1) were used for these experiments. As shown in
Figure 3A there was a very low level of CXCR4 expres-
sion on both murine blood and bone marrow neutrophils,SDF-1 Inhibits Responses of Human Neutrophils to
CXCR2 Agonists, but Not CXCR1 Agonists, In Vitro comparable to the levels of expression observed on
human blood neutrophils (Figure 1A). For the chemo-To determine the functional significance of CXCR4 ex-
pression on freshly isolated human neutrophils, a shape taxis assays, a mixed population of murine bone marrow
Function of CXCR4 on Neutrophils
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Figure 2. Neutrophil Shape Change Responses to the Chemokines Gro-, ENA-78, NAP-2, IL-8, and SDF-1
(A) Gro- (closed circles), SDF-1 (closed diamonds), 25 nM SDF-1  Gro- (closed triangles), AMD-3100 (5 g/ml)  25 nM SDF-1a 
Gro- (open circles). Each point represents the mean  SEM of n  3 independent experiments. *, P  0.05 (Kruskall Wallis H test) represents
a significant difference between the groups (Gro- alone or Gro-  SDF-1  AMD-3100) and the group (Gro-  SDF-1).
(B) IL-8 (open squares), 25 nM SDF-1  IL-8 (closed squares).Each point represents the mean  SEM of n  3 independent experiments.
(C, D, E, and F) Neutrophil shape change in response to Gro-, ENA-78, and NAP-2 and IL-8 (all at 10 nM) a,  300 nM SB225002; b,  25
nM SDF-1; c,  25 nM SDF-1  5 g/ml AMD-3100; d,  25 nM SDF-1a  5 g/ml anti-CXCR4 pAb. Each point represents the mean 
SEM of n  3–5 independent experiments. *, P  0.05 (Kruskall Wallis H test).
(G) Freshly isolated human blood neutrophils were incubated for 0–60 min with SDF-1 (50 nM). Surface expression of CXCR2 was then
determined by flow cytometry. Results are expressed as mean  SEM of n  6 separate experiments performed in triplicate.
leukocytes was placed in the upper chamber of The CXCR2 Agonist, KC, and the CXCR4 Antagonist,
AMD-3100, Act Cooperatively to StimulateTranswell filters in the presence or absence of SDF-1.
The murine homolog of Gro-, KC, was placed in the a Blood Neutrophilia
We hypothesized that endogenous SDF-1, present inlower chamber. As shown in Figure 3B, the chemotaxis
of neutrophils toward KC was significantly inhibited the bone marrow, might attenuate the release of neutro-
phils from the bone marrow in response to systemically(59%) by the presence of SDF-1 in the upper well. This
inhibition was reversed by pretreatment of the neutro- acting CXCR2 chemokines. In order to investigate this
possibility, mice were given a single i.v. injection of,phils with AMD-3100, demonstrating that the inhibitory
effect of SDF-1 was mediated via CXCR4. PBS, SDF-1, KC, AMD-3100, or KC plus AMD-3100.
After 60 min, the mice were killed and the number ofWhen similar chemotaxis assays were performed with
human neutrophils, we observed a significant inhibition blood and bone marrow neutrophils were determined
as shown in Figure 4. Our results showed that KC and(24%) of chemotaxis to Gro-, with no effect on neutro-
phil chemotaxis to IL-8 (results not shown). AMD-3100 when injected alone stimulated a 5- and
3-fold increase in circulating numbers of neutrophils,Taken together, these results show that neutrophil
migration to CXCR2 ligands are attenuated by SDF-1 respectively, while coinjection of KC together with AMD-
3100 resulted in a 15-fold increase in circulating neutro-acting via CXCR4.
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Figure 3. Murine Neutrophils Express Low
Levels of CXCR4, but SDF-1 Inhibits KC
Stimulated Neutrophil Chemotaxis
(A) Surface expression of CXCR4 on murine
blood and bone marrow neutrophils mea-
sured by flow cytometry; n  6 mice, bars
express the median.
(B) Neutrophil chemotaxis assay. Murine
bone marrow leukocytes were added to the
upper chamber of the Transwell filters in the
presence or absence of SDF-1 (10 nM),
AMD-3100 (5 g/ml), or both reagents. KC
(50 nM), SDF-1 (10 nM), or AMD-3100 (5 g/
ml) was added to the lower chamber as indi-
cated. Migration of neutrophils is expressed
as the chemotactic index, mean  SEM (n 
3–5 separate experiments performed in tripli-
cate). *, P  0.05 (Kruskall Wallis H test).
phil numbers (Figure 4A). The blood neutrophilia period that was significantly enhanced by infusion of
either KC or AMD-3100 alone (8.2  1.4  103/ml perfu-observed in response to KC, AMD-3100, and KC plus
AMD-3100 was mirrored by a reduction in bone marrow sate, 8.6  1.7  103/ml perfusate, respectively) while
infusion of the two factors together significantly aug-neutrophil numbers (Figure 4B), suggesting that the in-
crease in blood neutrophils was due to their release mented neutrophil mobilization (23.4 2.1 103/ ml per-
fusate).from the bone marrow. Administration of a single dose
of SDF-1 intravenously did not stimulate the acute mo- In contrast, while AMD-3100 also mobilized B cells
from the bone marrow KC alone did not mobilize B cellsbilization of neutrophils from the bone marrow.
significantly. Furthermore, KC did not enhance B cell
release stimulated by AMD-3100 (Figure 5B). Finally,Direct Evidence that the CXCR2 Agonist, KC, and the
CXCR4 Antagonist, AMD-3100, Act Cooperatively to infusion of SDF-1 (50 nM) did not stimulate the acute
release of either B cells or neutrophils from the boneMobilize Neutrophils from the Bone Marrow
To determine directly whether the increase in circulating marrow (Figures 5A and 5B).
Collectively, these data support the hypothesis thatneutrophils induced by the intravenous injections of KC,
AMD-3100, or KC plus AMD-3100 is due to neutrophil endogenous SDF-1 plays a role in the retention of neu-
trophils in the bone marrow. Hence, neutrophil releaserelease from the bone marrow, we set up an in situ
perfusion system of the mouse femoral bone marrow. In from the bone marrow in response to KC is markedly
increased by blocking CXCR4 with AMD-3100.this system, the femoral artery and vein are cannulated in
situ such that the femoral bone marrow can be perfused
in isolation and the leukocytes released from the bone CXCR4 Is Upregulated on Murine Bone Marrow
Neutrophils as They Agemarrow collected as they exit via the femoral vein. KC,
AMD-3100, or KC and AMD-3100 were infused for 10 min As shown in Figure 6A, cell surface expression of CXCR4
was dramatically upregulated on murine bone marrowdirectly into the mouse femoral artery and the leukocytes
mobilized from the femoral bone marrow over a perfu- neutrophils after 6 and 20 hr in culture. This increase in
expression was apparent on the total neutrophil popula-sion period of 60 min were collected. The number of
neutrophils and B cells released into the perfusate were tion. These changes in levels of receptor expression
were reflected by changes in functional responsiveness,determined by Flow cytometry. B cells were quantified
to determine whether the observed effects were cell- as the ability of 6 and 20 hr cultured neutrophils to
migrate toward SDF-1 was significantly increased astype specific. As shown in Figure 5A, there was a basal
release of neutrophils (PBS, 1.35  0.3  103/ ml perfu- compared to freshly isolated bone marrow neutrophils
(Figure 6B).sate) from the bone marrow over the 60 min perfusion
Figure 4. In Vivo Neutrophil Mobilization in
Mice following the Intravenous Injection of
KC and AMD-3100 Alone or In Combination
BALB/c mice were injected with either PBS,
SDF-1 (40 mg/kg), KC (40 mg/kg), AMD-
3100 (5 mg/kg), or AMD-3100 plus KC. The
number of circulating neutrophils per ml of
blood (A), and the number of bone marrow
neutrophils per femur (B), 60 min following
the i.v. injections. Results are expressed as
mean  SEM. (n  6). *, P  0.05 (Kruskall
Wallis H test).
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Figure 5. Mobilization of Neutrophils and B
Cells from the Perfused Femoral Bone Mar-
row in Mice following the Infusion of KC and
AMD-3100 alone or In Combination
(A) The number of neutrophils (Gr-1) and (B)
the number of B cells (B220) mobilized from
the bone marrow following 10 min infusion of
PBS, SDF-1 (50 nM), KC (50 nM), AMD-3100
(5 g/ml), or AMD-3100 plus KC. Results ex-
pressed as mean  SEM (n  5 separate
perfusions). *, P  0.05 (Kruskall Wallis H
test).
As neutrophils age in culture they become apoptotic Senescent CXCR4high Neutrophils Home
to the Bone Marrow and Traffic intoand can be readily identified by their binding of annexin
V. Analysis of the neutrophils cultured for 20 hr revealed the Hematopoietic Compartment
As SDF-1 is expressed constitutively in several tissuesthat 76  5% of these neutrophils were apoptotic (as
assessed by FITC-annexin V binding). However, expres- including the bone marrow, it is feasible that senescent,
preapoptotic neutrophils that express CXCR4 and havesion levels of CXCR4 were not significantly different
between the apoptotic and nonapoptotic populations. the capacity to migrate toward SDF-1 preferentially
home to these tissues in vivo. Experiments were there-Interestingly, we observed that in the chemotaxis assays
it was only the nonapoptotic/annexinV negative neutro- fore carried out to determine whether senescent neutro-
phils home to the bone marrow. Murine bone marrowphils that migrated toward SDF-1 (data not shown).
Figure 6. Trafficking of Neutrophils to the
Bone Marrow In Vivo
(A) Surface expression of CXCR4 on freshly
isolated (0 hr), 6 hr, and 20 hr cultured murine
bone marrow neutrophils measured by flow
cytometry. Results represent the mean 
SEM (n  5).
(B) Chemotaxis assay of freshly isolated (0
hr), 6 hr, and 20 hr cultured neutrophils to
SDF-1 (50 nM). Results represent the
mean  SEM (n  3 separate experiments
performed in triplicate).
(C and D) Bone marrow leukocytes cultured
for 0 hr (CXCR4low) or 6 hr (CXCR4high) at 37C
were labeled with FITC- and APC-conjugated
anti-Gr-1 mAb, respectively.
(C) A representative flow cytometry plot of
bone marrow harvested from a BALB/c
mouse 60 min following an i.v. injection with
a 1:1 mix of CXCR4low FITC neutrophils and
CXCR4high APC neutrophils.
(D) Results show the number of CXCR4low and
CXCR4high neutrophils per femur as deter-
mined by flow cytometry. Mean SEM of n
5 experiments.
(E and F) Confocal microscopy showing the
localization of CXCR4high neutrophils in the re-
cipient bone marrow 20 hr after iv injection
of CXCR4high neutrophils alone. Bars, 25 m
(E) and 10 m (F).
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leukocytes were harvested from donor mice and incu- without the possibility of differential sequestration in
other tissues. Under these conditions, 5.6 times morebated in RPMI 1640 for 6 hr at 37C or used immediately.
The level of apoptosis, as judged by annexin V staining CXCR4high neutrophils were sequestered in the bone
marrow than CXCR4lowneutrophils (Figures 7A–7C). Towas 24% of the population of neutrophils that had
been cultured for 6 hr. CXCR4 expression (geo mean determine whether sequestration is mediated via
CXCR4, CXCR4high Gr-1 leukocytes were either pre-fluorescence) on the freshly isolated and 6 hr cultured
neutrophils was 5  0.4 and 76.3  12.7, respectively treated with anti-CXCR4 blocking pAb (10 g/ml) or de-
sensitized by stimulation with 50 nM SDF-1 for 10 min.(Figure 6A); hence these two neutrophil populations
were termed CXCR4low and CXCR4high. Bone marrow Some of these leukocytes were taken for in vitro chemo-
taxis assays. These studies showed that chemotaxis ofCXCR4low and CXCR4high neutrophils were then labeled
with FITC- and APC-conjugated Gr-1 mAb, respectively. CXCR4high neutrophils toward 50 nM SDF-1 in vitro was
reduced by 55% by pAb pretreatment and by 85% byThe two leukocyte populations were subsequently
mixed 1:1 and then injected intravenously into a recipi- SDF-1 desensitization. The remaining leukocytes (un-
treated, desensitized with SDF-1, treated with controlent mouse. After 1 hr the mice were killed, femurs re-
moved, and the bone marrow harvested. The number or anti-CXCR4 blocking pAbs) were infused directly into
the femoral bone marrow of individual mice using theof FITC-labeled neutrophils and APC-labeled neutro-
phils in the harvested bone marrow was then determined in situ perfusion system (Figures 7D–7I). Sequestration
of CXCR4high neutrophils was significantly reduced byby Flow cytometry. From Figures 6C and 6D it is clear
that there are significantly more APC-labeled CXCR4high pAb pretreatment (57%) and by SDF-1 desensitization
(79%). Thus, sequestration of CXCR4high neutrophilsneutrophils present in the bone marrow than FITC-
labeled CXCR4low neutrophils. within the bone marrow was significantly reduced by
blocking the SDF-1/CXCR4 axis. These data indicateTo determine whether the CXCR4high neutrophils traffic
into the hematopoietic compartment of the bone mar- that the homing of senescent neutrophils back to the
bone marrow is mediated via CXCR4.row, 6 hr cultured neutrophils were incubated with unla-
beled Gr-1 mAb or an isotype control and then injected
intravenously into mice. After 12 hr the mice were killed Discussion
and the bone marrow harvested and processed for mi-
croscopy according to Experimental Procedures. The In this study we have examined the functional signifi-
injected neutrophils were detected with a FITC-labeled cance of CXCR4 expression on neutrophils. Consistent
secondary mAb. No staining was observed in bone mar- with previous reports, we have shown that freshly iso-
row harvested from mice injected with leukocytes lated human blood neutrophils and murine blood and
treated with the control mAb and then processed and bone marrow neutrophils express low levels of CXCR4
stained with secondary mAb (data not shown). Figures and do not migrate in response to SDF-1. In a more
6E and 6F show representative sections of bone marrow sensitive shape change assay a small, but consistent,
harvested from mice injected with Gr-1 labeled CXCR4high response of human neutrophils to SDF-1 was ob-
neutrophils at low and high power. It can be seen from served. While CXCR4 was expressed at extremely low
these sections that the CXCR4high neutrophils that home levels on freshly isolated neutrophils we observed high
to the bone marrow are observed in the hematopoietic levels of intracellular staining for this receptor. This re-
compartment of the bone marrow; i.e., these cells are ceptor distribution may be explained by a high level of
able to attach to and migrate through the sinus endothe- spontaneous endocytosis of CXCR4, as has previously
lium into the stroma. been reported in other cell types (Tarasova et al., 1998).
We show here, for the first time, that the response of
human and murine neutrophils to CXCR2-acting chemo-Sequestration of Neutrophils within the Bone
Marrow Is Mediated via CXCR4 kines is significantly inhibited when the neutrophils were
costimulated with SDF-1. The results presented showWhen neutrophils are injected intravenously into mice
they distribute predominantly between the lung, bone inhibition using optimal concentrations of SDF-1 , as
determined in preliminary experiments. Thus, maximalmarrow, liver, and spleen (Suratt et al., 2001). Thus, it
is possible that we observed relatively more CXCR4high inhibition was never more than 60%. We have shown
that this inhibition is mediated via CXCR4 as it is abro-neutrophils homing to the bone marrow because the
CXCR4low neutrophils were selectively taken up into gated both by the specific CXCR4 antagonist, AMD-
3100, and the CXCR4 blocking mAb (Hatse et al., 2002).other tissues. The next set of experiments were there-
fore designed to compare the sequestration of neutro- The ability of SDF to mediate this effect despite the low
level of CXCR4 expression on freshly isolated neutro-phils by the bone marrow alone. Freshly isolated
(CXCR4low) or 6 hr cultured (CXCR4high) neutrophils la- phils is consistent with a previous report of crossregula-
tion of CXCR4 by CCR5 in B cell progenitors that expressbeled with APC-conjugated Gr-1 mAb were infused di-
rectly into the femoral bone marrow of separate mice. barely detectable levels of CCR5 (Honczarenko et al.,
2002). Our data are in contrast to a recent report thatLeukocytes were infused via the femoral artery over a
period of 30 min using the in situ perfusion system of shows that IL-8 acting via CXCR1, but not CXCR2, re-
duces the responsiveness of monocytes to SDF-1the mouse femoral bone marrow. After a further 30 min
perfusion, the femur was removed and the femoral bone (Richardson et al., 2003); this is most likely a reflection
of the difference in the cell type used for each study.marrow harvested. This system allowed us to determine
directly the relative number of CXCR4low and CXCR4high The crossregulation of CXCR2 by CXCR4 observed
in this study does not appear to be the result of heterolo-neutrophils that were sequestered in the bone marrow,
Function of CXCR4 on Neutrophils
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Figure 7. Sequestration of CXCR4high Neutrophils within the Bone Marrow Is Mediated via CXCR4
Murine bone marrow leukocytes were cultured at 37C for 0 hr (CXCR4low) (A) or 6 hr (CXCR4high) (B, D, E, G, and H). Neutrophils were
subsequently left untreated (A and B) or preincubated with a CXCR4 blocking Ab (E) or an isotype matched control Ab for 30 min (D), or
incubated for 10 min in the presence (H) or absence (G) of SDF-1 (50 nM). All neutrophil populations were then labeled with APC-conjugated
GR-1mAb. Using the in situ perfusion system of the mouse femoral bone marrow the different populations of bone marrow leukocytes were
infused directly into the femoral bone marrow over a period of 30 min. The femoral bone marrow was harvested and the number of Gr-1
neutrophils determined by flow cytometry. Results show the number of Gr-1 labeled neutrophils per femur (C, F, and I) Mean  SEM of n 
5 experiments. A representative flow cytometry plot from a BALB/c mouse injected with Gr-1 APC conjugated leukocytes is shown (A, B,
D, E, G, and H). (J) A model for the role of the CXCR4/SDF-1pathway in neutrophil release and return to the bone marrow is shown schematically.
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gous receptor downregulation, as cell surface expres- vation of plasma levels of SDF-1 effects a leukocytosis
(Hattori et al., 2001). However, the mechanism underly-sion of CXCR2 was unaffected by incubation of neutro-
phils with SDF-1. It seems likely, therefore, that the ing this response appears to be indirect.
Our results support the hypothesis that endogenouscrosstalk between CXCR4 and CXCR2 is mediated ei-
ther via receptor desensitization or via inhibition of spe- bone marrow SDF-1 plays an important role in the
retention of mature neutrophils within the bone marrow.cific downstream signaling elements. Interestingly, in
human neutrophils, we found that SDF-1 reduced re- There are currently four other indirect lines of evidence
that support this hypothesis. First, it has been shownsponses to chemokines acting via CXCR2 but not
CXCR1. This difference may reflect a difference in the that irradiated WT mice reconstituted with bone marrow
derived from CXCR4-deficient mice have fewer maturesignal transduction pathways utilized by these two re-
ceptors or a difference in the susceptibility of these two neutrophils in the bone marrow and higher numbers of
circulating myeloid cells (Ma et al. 1999), suggestingreceptors to desensitization (Haribabu et al., 2000). The
biological significance of this finding remains to be es- that in the absence of CXCR4 mature neutrophils are
not retained within the bone marrow reserve. Second,tablished, although it may relate to the distinct functions
suggested for these two receptors (White et al., 1998). treatment of mice with G-CSF reduces bone marrow
SDF-1 levels and this is associated with the mobiliza-During acute inflammatory reactions, an elevation of
systemic levels of inflammatory mediators such as the tion of bone marrow neutrophils (Semerad et al., 2002).
Third, an i.v. injection of the CXCR4-antagonist, AMD-CXC chemokines stimulates the acute mobilization of
neutrophils from the bone marrow. Based on our in vitro 3100, has been shown to induce a leukocytosis in hu-
mans (Hendrix et al., 2000). Finally, our results wouldfindings showing a negative crosstalk between CXCR4
and CXCR2, we hypothesized that endogenous SDF- explain the data recently reported by Hernandez et al.
that patients with WHIM syndrome express an activating1, present in the bone marrow, acts as a retention
factor for bone marrow neutrophils, limiting neutrophil mutation of CXCR4 (Hernandez et al. 2003). Thus cells
expressing this mutated CXCR4 receptor were shownrelease in response to elevated systemic levels of
CXCR2-acting chemokines. To test this hypothesis, we to exhibit enhanced signaling in response to SDF-1.
These patients exhibit a blood neutropenia despite hav-examined whether blocking CXCR4 signaling, using
AMD-3100, would potentiate neutrophil mobilization ing normal numbers of mature neutrophils in the bone
marrow. Thus, it has been suggested that they sufferstimulated by the CXCR2-acting chemokine KC. Our
data showed that neutrophils may be mobilized either with a defect in neutrophil release from the bone marrow.
The results of Hernandez et al. suggest that neutrophilsdirectly by stimulating neutrophil chemotaxis or indi-
rectly by blocking the effect of SDF-1. Furthermore, derived from patients with WHIM syndrome would ex-
hibit a hyperresponsiveness to SDF-1 as compared towe showed that AMD-3100 and KC acted synergistically
with respect to neutrophil mobilization when coinjected. those derived from normals. Hence we would predict
that the ability of endogenous SDF-1 to retain matureThese results indicate that maximal mobilization of neu-
trophils, stimulated by CXCR2-acting chemokines, is neutrophils in the bone marrow would be enhanced in
these patients, thus resulting in a blood neutropenia.dependent on blockade of the CXCR4-dependent path-
way that promotes the retention of neutrophils in the In this study, consistent with the report of Nagase et
al. (2002), we showed that expression of CXCR4 wasbone marrow. We observed that the cooperative effect
of AMD-3100 and KC was selective for neutrophils, as dramatically upregulated on murine bone marrow neu-
trophils cultured for 6 and 20 hr. Moreover, these neutro-B cell release was only enhanced by AMD-3100 and not
KC and was not potentiated when AMD and KC were phils gained the ability to migrate toward SDF-1. On
human neutrophils we have shown that upregulation ofinfused together.
While it is likely that neutrophil mobilization stimulated CXCR4 occurs when these cells are cultured in autolo-
gous serum, suggesting that this process may occur inby KC is mediated via a direct action of KC on neutrophil
motility, it is also possible that indirect mechanisms vivo in the circulation (C.M., unpublished data). Impor-
tantly, upregulation of CXCR4 on murine neutrophilsoperate to effect this release as has been proposed for
the basal release of neutrophils stimulated by G-CSF preceded neutrophil apoptosis (as defined by annexin
V staining) and we showed that it was the nonapoptotic,(Semerad et al., 2002). For example, it has recently been
shown that CD34 cells are mobilized through inactiva- CXCR4high neutrophils that had the capacity to migrate
toward SDF-1. Apoptotic neutrophils did not migratetion of SDF-1 and CXCR4 by serine proteases, such
as neutrophil elastase or cathepsin G released from neu- toward SDF-1.
When equal numbers of CXCR4low and CXCR4high neu-trophils (Levesque et al. 2003). These proteases may,
therefore, similarly be involved in neutrophil release in trophils were injected i.v. into mice or infused directly
into the bone marrow using the in situ perfusion system,response to KC.
When SDF-1 was administered acutely as a single significantly more CXCR4high neutrophils were present
in the femoral bone marrow as compared to CXCR4lowi.v. injection in vivo or as a 10 min infusion in the bone
marrow perfusion system in situ, it did not stimulate neutrophils after one hour. This data suggests that
CXCR4high neutrophils preferentially home to the boneneutrophil mobilization, measured over 60 min. This indi-
cates that intravascular SDF-1 does not promote the marrow. Furthermore using either anti-CXCR4 blocking
pAb or SDF-1 desensitization protocol we have shownrapid mobilization of bone marrow neutrophils, when a
chemotactic gradient is established across the sinus that the sequestration of senescent CXCR4high neutro-
phils in the femoral bone marrow is CXCR4 dependent.endothelium. This result is consistent with our in vitro
findings that SDF-1 does not stimulate neutrophil che- Confocal microscopy of the bone marrow revealed
that CXCR4high neutrophils traffic into the hematopoieticmotaxis. Previous studies have shown that chronic ele-
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UK). Recombinant chemokines, KC, Gro-, ENA-78, NAP-2, IL-8,compartment of the bone marrow. This is evidence that
and SDF-1 were from PeproTech EC Ltd. (London, UK). The PE-these senescent neutrophils are not merely being
conjugated mouse anti-human CXCR4 mAb (clone 12G5) and mouselodged in the bone marrow sinuses but are migrating
IgG2a isotype control (clone 20102.1), the FITC-conjugated mouse
across the sinusoidal endothelium into the hematopoi- anti-human CXCR2 mAb (clone 48311.211) and mouse IgG2a iso-
etic compartment. These data suggest that the SDF- type control (clone 20102.1) were obtained from R&D Systems. Puri-
fied mouse anti-human CXCR4 mAb (clone 12G5), PE-conjugated1-stimulated migration of CXCR4high neutrophils may
rat anti-mouse CXCR4 mAb (clone 2B11/CXCR4) and rat IgG2bplay a role in the homing of senescent neutrophils back
isotype control (clone A95-1), purified, FITC-conjugated or APC-to the bone marrow. It is important to point out that our
conjugated rat anti-mouse Ly-6G (Gr-1) mAb (clone RB6-8C5), PE-study does not exclude the possibility that senescent
conjugated rat anti-mouse CD45R/B220 mAb (clone RA3-6B2), rat
neutrophils may also home to other tissues expressing anti-mouse CD16/CD32 (Fc	 III/II Receptor) mAb (clone 2.4G2) were
SDF-1, such as the spleen and liver. Hence this mecha- obtained from BD Biosciences. FITC-conjugated mouse anti-human
CD16 mAb (clone DJ130c) was obtained from DAKO (Ely, UK). Thenism may also contribute to neutrophil clearance via
CXCR2 antagonist SB225002 was obtained from Calbiochem. ACKthese tissues.
lysis is composed of 0.15 M NH4Cl, 1 mM KHC03, and 0.1 mMThe fact that neutrophils expressing high levels of
Na2EDTA. Perfusion buffer is a modified Krebs-Ringer bicarbonateCXCR4 have not been observed in the circulation sug-
buffer supplemented with 10 mM D-Glucose, 2.50 mM CaCl2, 0.49
gests that, if these cells do exist in vivo, then they are mM MgCl2.6H20, 4.56 mM KCl, 120 mM NaCl, 0.7 mM Na2HPO4,
rapidly cleared from the circulation. To date, the only and 24 mM NaHC03, and Ficoll T-70 4% and BSA 0.1%. The CXCR4-
antagonist, AMD-3100, was a generous gift from Dr. Gary Bridger,report of neutrophils expressing high levels of CXCR4
AnorMED Inc., British Columbia, Canada. The rabbit polyclonal anti-in vivo is on neutrophils present in the synovial fluid of
mouse CXCR4-blocking Ab (Gonzalo et al., 2000) was a generous giftpatients with inflammatory joint diseases (Bruhl et al.,
from Dr. Jose-Carlos Gutierrez-Ramos (Millennium Pharmaceuticals2001). It is likely that these neutrophils do not reenter
Inc., Cambridge, Massachusetts).
the circulation, but are cleared via tissue macrophages.
Our results provide a mechanism to explain the results Isolation of Human Peripheral Blood PMNs
of Suratt et al. (2001), who showed that up to 65% of Human PMNs were isolated from the peripheral venous blood as
previously described (Haslett et al., 1985). In brief, blood was col-purified 111In-labeled bone marrow neutrophils were se-
lected into citrate (3.8%) and centrifuged to remove the plasma.questered in the bone marrow 4 hr following their i.v.
The cell pellet was resuspended in 6% dextran solution and leftinjection in mice. They are also consistent with the ob-
for 30 min to sediment the erythrocytes. The leukocyte layer wasservations of Saverymuttu et al. (1985), who studied the
carefully removed and layered onto Histopaque-1077 and centri-
fate of 111In-labeled autologous granulocytes following fuged. The pellet containing erythrocytes and PMNs was lysed by
their i.v. injection in humans. 24 hr after their injection hypotonic shock.
the distribution of the granulocytes was visualized using
a 	 camera and a signal was observed from the bone Preparation of Murine Bone Marrow Leukocytes
The right femur was removed, and the femoral bone marrow wasmarrow, indicating homing of mature granulocytes back
harvested by flushing with 5 ml HBSS buffer (Hanks Balanced Saltsto the bone marrow in humans.
with Ca2/Mg2, 30 mM Hepes, 0.1% low endotoxin BSA [pH 7.4]).The results of this study show that the SDF-1/CXCR4
The erythrocytes were removed using hypotonic shock and the
chemokine axis serves as an important retention path- leukocyte population was resuspended in HBSS buffer.
way for bone marrow neutrophils, regulating the extent
of neutrophil mobilization that occurs in response to an Chemokine Receptor Expression on Neutrophils
Neutrophil surface CXCR4 expression was examined on (1) freshlyelevation in systemic levels of CXC chemokines (Figure
isolated blood human PMNs, (2) human PMNs cultured for 20 hr in7J). At a cellular level, we have shown that this effect is
RPMI 1640 supplemented with 10% heat-inactivated fetal calf se-due to the ability of SDF-1 to reduce the respon-
rum, 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/ml strepto-siveness of neutrophils to CXCR2-acting chemokines.
mycin, (37C), (3) murine whole blood and bone marrow leukocyte
The expression of CXCR4 on senescent neutrophils and suspension, and (4) murine bone marrow cultured for 6 or 20 hr.
their ability, unlike their nonsenescent counterparts, to Human neutrophils were identified by their characteristic forward/
side scatter (FCS/SSC) and/or CD16-positive staining. Neutrophilsmigrate toward SDF-1, suggested that these cells may
were preincubated with human serum for 15 min and then stainedpreferentially traffic to tissues expressing SDF-1. In-
with anti-CXCR4-PE (50 g/ml) or a PE-labeled isotype matcheddeed, we have shown here that CXCR4high senescent
control mAb and anti-CD16-FITC (3.33 g/ml) for 20 min. CXCR2neutrophils preferentially home to the bone marrow in
expression was also analyzed using anti-CXCR2-FITC (5 g/ml) or
a CXCR4-dependent manner (Figure 7J). We propose a FITC-labeled isotype matched control mAb. Murine neutrophils
that this pathway may represent a previously undefined were identified by their characteristic FCS/SSC and Gr-1 positive
staining. Neutrophils were preincubated with murine Fc block andpathway for the basal clearance of senescent neutro-
then stained with anti-CXCR4-PE (20 g/ml) or a PE-labeled isotypephils from the circulation and thus is of fundamental
matched control mAb and anti-Ly-6G (Gr-1)-APC (20 g/ml). Theimportance for neutrophil homeostasis.
samples were run on a FACSCalibur flow cytometer (BD Biosci-
ences, Oxford, UK), and analyzed using CellQuest software.
Experimental Procedures
Measurement of Neutrophil Shape Change Using
Clinical Samples and Animals Flow Cytometry
Whole blood was obtained by venipuncture from healthy human 5  105 purified PMNs in cell buffer (PBS, 10 mM HEPES, 10 mM
volunteers. Female BALB/c mice were purchased from Harlan (Ox- glucose, and 0.1% BSA [pH 7.2–7.4]) were incubated with chemo-
ford, UK) and used at 6 weeks old. kines or buffer in a final volume of 100 l, at 37C for 4 min. The
cells were then fixed on ice by addition of 250 l of ice-cold fixative
(a 1/4 dilution of Cellfix from BD Biosciences, Oxford, UK). In someReagents
General laboratory and cell culture reagents were purchased from experiments, PMN were preincubated with SDF-1 (25 nM) or
CXCR2 antagonist (300 nM) for 5 min, prior to the addition of chemo-either Life Technologies (Paisly UK) or Sigma Chemical Co. (Poole,
Immunity
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kines. Some cells were preincubated for 10 min with the CXCR4 Comparison of Homing Capacity of Bone Marrow of Neutrophils
Expressing High or Low Levels of CXCR4antagonist AMD-3100 (5 g/ml) or anti-human CXCR4 blocking mAb
(5 g/ml) before being incubated with SDF-1 (25 nM) for a further 20  106 murine bone marrow leukocytes prepared as above (at
least 40% neutrophils) were cultured for 0 or 6 hr in RPMI supple-5 min and then with the chemokines. The samples were run on
a FACSCalibur flow cytometer (BD Biosciences, Oxford, UK), and mented with 10% heat-inactivated fetal calf serum, 2 mM L-gluta-
mine, 100 U/ml penicillin, and 100 mg/ml streptomycin (37C). 0 andanalyzed using CellQuest software as previously described (Sabroe
et al., 1997). Acquisition was terminated after 5000 neutrophil events. 6 hr cultured bone marrow leukocytes were then incubated with 50
l anti-Ly-6G (Gr-1)-FITC (20 g/ml) or 50 l anti-Ly-6G (Gr-1)-APCResults are expressed as the change from baseline in forward scat-
ter of neutrophil population in response to chemokines, and is the (20 g/ml), respectively, for 30 min on ice. Leukocytes were washed
twice with RPMI 1640 and a sample of each preparation was pro-mean of three separate experiments.
cessed by flow cytometry analysis to check the percentage of Gr-1
neutrophils. The two populations were mixed 1:1 in a final volumeNeutrophil Chemotaxis Assay
of 0.2 ml RPMI 1640 and were injected in BALB/c mice via the tailMurine bone marrow leukocytes (3 106 cells in 0.2 ml assay buffer)
vein. After 1 hr the femoral bone marrow was removed and analyzedor isolated human PMNs (0.5  106 in 0.2 ml assay buffer) were
by flow cytometry for either Gr-1-APC positive neutrophils or Gr-1-placed in the upper chamber of Transwell filters, Millipore (3 m
FITC positive neutrophils.pore diameter) that were in turn placed in individual wells of a 24-
For infusion directly into the bone marrow 0 or 6 hr culturedwell cell culture plate containing 0.3 ml of assay buffer with or
leukocytes were labeled with 50 l anti-Ly-6G (Gr-1)-APC (20 g/without chemokine (KC 50 nM, SDF-1 50 nM or 10 nM, IL-8 1 nM,
ml) for 30 min on ice and resuspended in 0.5 ml perfusion buffer.and Gro- 10 nM). In some experiments, the cells were preincubated
Some 6 hr cultured leukocytes were preincubated for 30 min withat 37C with SDF-1 (50 nM) for 5 min and/or AMD-3100 (5 g/ml)
anti-CXCR4 mAb or rat isotype matched control mAb, or preincu-for 15 min before being placed in the upper Transwell chamber.
bated with SDF-1 (50 nM for 10 min at 37C) and then washed.Chambers were incubated for 60 min at 37C. The number of neutro-
The hind limb was perfused as described above and leukocytesphils that migrated into the bottom chamber were determined by a
were infused over 30 min. After 60 min the femoral bone marrowFACSCalibur flow cytometer (BD Biosciences, Oxford, UK), with
was removed and the number of Gr-1 positive neutrophils retainedrelative cell counts obtained by acquiring events for a set time period
in the bone marrow was determined by flow cytometry.of 30s.
Localization of CXCR4 High Expressing Neutrophil within theIn Vivo Neutrophil Mobilization in Mice
Haematopoitic Compartment via Confocal Laser MicroscopyBALB/c mice were injected with either KC (40 g/kg), AMD-3100 (5
6 hr cultured murine bone marrow neutrophils were incubated withmg/kg), SDF-1 (40 g/kg), or PBS only via the tail vein. A fifth group
unlabeled Gr-1 mAb or an isotype control mAb. These leukocytesof mice received an i.v.injection of both AMD-3100 (5 mg/kg) and
were then injected intravenously into mice. After 12 hr the mice wereKC (40 g/kg). In this case mice were injected with AMD-3100 20
killed and the bone marrow harvested, embedded in gelatin, andmin prior to the administration of KC. After 60 min, the mice were
snap frozen. 3m sections were incubated for 1 hr at room tempera-anaesthetized with intraperitoneal injection of ketamine (100 mg/
ture with PBS supplemented with 5% BSA, washed with PBS, andkg)/xylazine (10 mg/kg). Blood (0.5–1 ml) was collected by cardiac
then incubated with a FITC-labeled secondary rabbit anti-rat anti-puncture into EDTA (100 mM), the erythrocyte population was re-
body (diluted 1/50) for 1 hr at room temperature. Slides were washedmoved using ACK lysis, and the sample was centrifuged and resus-
3 times in PBS and then mounted in Immuno Fluor medium (ICNpended in RPMI 1640. Femoral bone marrow cells were harvested
Biomedicals) and observed using a Leica DM-IRBE confocal micro-and the total number of nucleated cells was determined by light
scope. Images were processed using Leica TCS-NT software asso-microscopy using a Neubauer haematocytometer. For differential
ciated with the microscope and Adobe Photoshop 4.0 software.cell counts, blood or bone marrow leukocytes were preincubated
with 10g/ml rat anti-mouse CD16/CD32, washed, and then stained
Statisticswith 10 l anti-Ly-6G (Gr-1)-APC (20 g/ml) or 10 l anti-B220-PE
The nonparametric Kruskall-Wallis H test and the Mann-Whitney U(20 g/ml). The samples were analyzed by flow cytometry.
test were used to assess nonnormally distributed parameters.
In Situ Perfusion of the Murine Femoral Bone Marrow
AcknowledgmentsThe guinea pig hind limb perfusion technique previously described
(Palframan et al., 1998) was adapted to the mouse. Female BALB/c
This work was funded by the Wellcome Trust.mice were anaesthetized with intraperitoneal injection of ketamine
(100 mg/kg)/xylazine (10 mg/kg) and the external femoral artery and
veins were exposed. The hind limb was isolated by occlusion of the Received: April 11, 2003
Revised: July 21 2003external iliac artery, superficial epigastric and muscular branch with
5/0 braided silk suture. The animals were killed with Expiral (250 Accepted: August 20, 2003
Published: October 14, 2003mg/kg by intracardiac injection), and polyethylene cannulae (0.61
mm OD, Portex, London, UK) were immediately inserted into the
femoral artery and vein and tied in place with 5/0 braided silk suture. References
Perfusion buffer at 37C was infused (0.1 ml/min) via the arterial
cannula and removed from the venous cannula using a Minipuls Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A., and
peristaltic pump (Anachem, Luton, UK). The hind limb was perfused Springer, T.A. (1996). A highly efficacious lymphocyte chemoattrac-
for an initial 10 min to remove blood from the vasculature and then tant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184, 1101–
perfused for a further 60 min. The perfusate was collected onto ice 1109.
and centrifuged (200g for 10 min, 4C). Erythrocytes were lysed
Bleul, C.C., Wu, L., Hoxie, J.A., Springer, T.A., and Mackay, C.R.
using hypotonic shock and the cell pellet was resuspended and
(1997). The HIV coreceptors CXCR4 and CCR5 are differentially
stained as previously described with anti-Ly-6G (Gr-1)-APC and
expressed and regulated on human T lymphocytes. Proc. Natl. Acad.
anti-B220-PE. The samples were analyzed by flow cytometry. The
Sci. USA 94, 1925–1930.
total number of events recorded by the flow cytometer was used
Bruhl, H., Wagner, K., Kellner, H., Schattenkirchner, M., Schlondorff,to calculate the number of cells mobilized from the hind limb during
D., and Mack, M. (2001). Surface expression of CC- and CXC-che-the 60 min perfusion. In some experiments, KC (50 nM), AMD-3100
mokine receptors on leucocyte subsets in inflammatory joint dis-(5 g/ml), SDF-1 (50 nM), or buffer alone were infused over a 10
eases. Clin. Exp. Immunol. 126, 551–559.min period using an infusion/withdrawal pump (Harvard Instruments,
UK). In other experiments, bone marrow leukocytes (prepared as Forster, R., Kremmer, E., Schubel, A., Breitfeld, D., Kleinschmidt,
A., Nerl, C., Bernhardt, G., and Lipp, M. (1998). Intracellular anddescribed below) were infused over a 30 min period using the
same pump. surface expression of the HIV-1 coreceptor CXCR4/fusin on various
Function of CXCR4 on Neutrophils
593
leukocytesubsets: rapid internalization and recycling upon activa- Mohle, R., Bautz, F., Rafii, S., Moore, M.A., Brugger, W., and Kanz,
L. (1998). The chemokine receptor CXCR-4 is expressed on CD34tion. J. Immunol. 160, 1522–1531.
hematopoietic progenitors and leukemic cells and mediates trans-Gonzalo, J.A., Lloyd, C.M., Peled, A., Delaney, T., Coyle, A.J., and
endothelial migration induced by stromal cell-derived factor-1.Gutierrez-Ramos, J.C. (2000). Critical involvement of the chemotac-
Blood 91, 4523–4530.tic axis CXCR4/stromal cell-derived factor-1 alpha in the inflamma-
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno,tory component of allergic airway disease. J. Immunol. 165, 499–508.
N.H., Matsushima, K., Yamamoto, K., Morita, Y., and Hirai, K. (2002).Haribabu, B., Richardson, R.M., Verghese, M.W., Barr, A.J., Zhelev,
Cytokine-mediated regulation of CXCR4 expression in human neu-D.V., and Snyderman, R. (2000). Function and regulation of chemoat-
trophils. J. Leukoc. Biol. 71, 711–717.tractant receptors. Immunol. Res. 22, 271–279.
Palframan, R.T., Collins, P.D., Severs, N.J., Rothery, S., Williams,Haslett, C. (1999). Granulocyte apoptosis and its role in the resolu-
T.J., and Rankin, S.M. (1998). Mechanisms of acute eosinophil mobi-tion and control of lung inflammation. Am. J. Respir. Crit. Care Med.
lization from the bone marrow stimulated by interleukin 5: the role160, S5–11.
of specific adhesion molecules and phosphatidylinositol 3-kinase.
Haslett, C., Guthrie, L.A., Kopaniak, M.M., Johnston, R.B., Jr., and J. Exp. Med. 188, 1621–1632.
Henson, P.M. (1985). Modulation of multiple neutrophil functions by
Patel, L., Charlton, S.J., Chambers, J.K., and Macphee, C.H. (2001).
preparative methods or trace concentrations of bacterial lipopoly-
Expression and functional analysis of chemokine receptors in hu-
saccharide. Am. J. Pathol. 119, 101–110.
man peripheral blood leukocyte populations. Cytokine 14, 27–36.
Hatse, S., Princen, K., Bridger, G., De Clercq, E., and Schols, D. Richardson, R.M., Tokunaga, K., Marjoram, R., Sata, T., and Sny-
(2002). Chemokine receptor inhibition by AMD-3100 is strictly con- derman, R. (2003). Interleukin-8-mediated heterologous receptor in-
fined to CXCR4. FEBS Lett. 527, 255–262. ternalization provides resistance to HIV-1 infectivity. Role of signal
Hattori, K., Heissig, B., Tashiro, K., Honjo, T., Tateno, M., Shieh, strength and receptor desensitization. J. Biol. Chem. 278, 15867–
J.H., Hackett, N.R., Quitoriano, M.S., Crystal, R.G., Rafii, S., et al. 15873.
(2001). Plasma elevation of stromal cell-derived factor-1 induces Sabroe, I., Hartnell, A., Jopling, L.A., Bel, S., Ponath, P.D., Pease,
mobilization of mature and immature hematopoietic progenitor and J.E., Collins, P.D., and Williams, T.J. (1999). Differential regulation
stem cells. Blood 97, 3354–3360. of eosinophil chemokine signaling via CCR3 and non-CCR3 path-
Hendrix, C.W., Flexner, C., MacFarland, R.T., Giandomenico, C., ways. J. Immunol. 162, 2946–2955.
Fuchs, E.J., Redpath, E., Bridger, G., and Henson, G.W. (2000). Saverymuttu, S.H., Peters, A.M., Keshavarzian, A., Reavy, H.J., and
Pharmacokinetics and safety of AMD-3100, a novel antagonist of Lavender, J.P. (1985). The kinetics of 111indium distribution follow-
the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. ing injection of 111indium labelled autologous granulocytes in man.
Agents Chemother. 44, 1667–1673. Br. J. Haematol. 61, 675–685.
Hernandez, P.A., Gorlin, R.J., Lukens, J.N., Taniuchi, S., Bohinjec, Semerad, C.L., Liu, F., Gregory, A.D., Stumpf, K., and Link, D.C.
J., Francois, F., Klotman, M.E., and Diaz, G.A. (2003). Mutations in (2002). G-CSF is an essential regulator of neutrophil trafficking from
the chemokine receptor gene CXCR4 are associated with WHIM the bone marrow to the blood. Immunity 17, 413–423.
syndrome, a combined immunodeficiency disease. Nat. Genet.
Suratt, B.T., Young, S.K., Lieber, J., Nick, J.A., Henson, P.M., and
34, 70–74.
Worthen, G.S. (2001). Neutrophil maturation and activation deter-
Honczarenko, M., Le, Y., Glodek, A.M., Majka, M., Campbell, J.J., mine anatomic site of clearance from circulation. Am. J. Physiol.
Ratajczak, M.Z., and Silberstein, L.E. (2002). CCR5-binding chemo- Lung Cell. Mol. Physiol. 281, L913–L921.
kines modulate CXCL12 (SDF-1)-induced responses of progenitor Tarasova, N.I., Stauber, R.H., and Michejda, C.J. (1998). Spontane-
B cells in human bone marrow through heterologous desensitization ous and ligand-induced trafficking of CXC-chemokine receptor 4.
of the CXCR4 chemokine receptor. Blood 100, 2321–2329. J. Biol. Chem. 273, 15883–15886.
Hori, T., Sakaida, H., Sato, A., Nakajima, T., Shida, H., Yoshie, O., Terashima, T., English, D., Hogg, J.C., and van Eeden, S.F. (1998).
and Uchiyama, T. (1998). Detection and delineation of CXCR-4 (fusin) Release of polymorphonuclear leukocytes from the bone marrow
as an entry and fusion cofactor for T-tropic [correction of T cell- by interleukin-8. Blood 92, 1062–1069.
tropic] HIV-1 by three different monoclonal antibodies. J. Immunol.
Thakur, M.L., Lavender, J.P., Arnot, R.N., Silvester, D.J., and Segal,160, 180–188.
A.W. (1977). Indium-111-labeled autologous leukocytes in man.J.
Jagels, M.A., and Hugli, T.E. (1992). Neutrophil chemotactic factors Nucleic Med. 10, 1014–1021.
promote leukocytosis. A common mechanism for cellular recruit-
White, J.R., Lee, J.M., Young, P.R., Hertzberg, R.P., Jurewicz, A.J.,
ment from bone marrow. J. Immunol. 148, 1119–1128.
Chaikin, M.A., Widdowson, K., Foley, J.J., Martin, L.D., Griswold,
Kowalska, M.A., Ratajczak, J., Hoxie, J., Brass, L.F., Gewirtz, A., D.E., et al. (1998). Identification of a potent, selective non-peptide
Poncz, M., and Ratajczak, M.Z. (1999). Megakaryocyte precursors, CXCR2 antagonist that inhibits interleukin-8-induced neutrophil mi-
megakaryocytes and platelets express the HIV co-receptor CXCR4 gration. J. Biol. Chem. 273, 10095–10098.
on their surface: determination of response to stromal-derived fac-
tor-1 by megakaryocytes and platelets. Br. J. Haematol. 104,
220–229.
Levesque, J.P., Hendy, J., Takamatsu, Y., Simmons, P.J., and Ben-
dall, L.J. (2003). Disruption of the CXCR4/CXCL12 chemotactic inter-
action during hematopoietic stem cell mobilization induced by GCSF
or cyclophosphamide. J. Clin. Invest. 111, 187–196.
Loetscher, P., Gong, J.H., Dewald, B., Baggiolini, M., and Clark-
Lewis, I. (1998). N-terminal peptides of stromal cell-derived factor-1
with CXC chemokine receptor 4 agonist and antagonist activities.
J. Biol. Chem. 273, 22279–22283.
Lovas, K., Knudsen, E., Iversen, P.O., and Benestad, H.B. (1996).
Sequestration patterns of transfused rat neutrophilic granulocytes
under normal and inflammatory conditions. Eur. J. Haematol. 56,
221–229.
Ma, Q., Jones, D., and Springer, T.A. (1999). The chemokine receptor
CXCR4 is required for the retention of B lineage and granulocytic
precursors within the bone marrow microenvironment. Immunity
10, 463–471.
